Certified by Founder Lodge
Sofinnova Partners
France - Paris, Ile-de-France
INVESTOR
1 Disclosed Funding Rounds $31,300,000
49 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a tea
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 15 ,2024 | Series B | Undisclosed Amount |
| Company | Date | Round | Raised |
|---|---|---|---|
 AAVantgarde Bio |
June, 07 ,2023 | Series A | $65,333,745 |
 Moon Surgical |
June, 30 ,2022 | Series A | $31,300,000 |
 Mediar Therapeutics |
March, 15 ,2023 | Unknown | $105,000,000 |
 Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
 Gradient Denervation Technologies |
September, 08 ,2023 | Series A | $15,015,000 |
 deepc |
March, 31 ,2023 | Series A | $13,062,000 |
 Mironid® Limited |
September, 14 ,2023 | Series A | |
 BioCorteX |
March, 31 ,2023 | Seed | $5,000,000 |
 Sitryx |
September, 28 ,2023 | Unknown | $39,500,000 |
 Kiro |
April, 03 ,2023 | Series A | $14,955,000 |
 Bon Vivant |
October, 13 ,2023 | Seed | $15,800,000 |
 Werewool |
May, 12 ,2023 | Seed | $3,700,000 |
 Betteromics |
October, 27 ,2023 | Series A | $20,000,000 |
 TISSIUM |
May, 23 ,2023 | Series D | $50,000,000 |
 l'école AI |
October, 27 ,2023 | Seed | $3,000,000 |
 BrightHeart |
June, 01 ,2023 | Seed | $2,151,000 |
 T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| AAVantgarde Bio |
June, 07 ,2023 | Series A | $65,333,745 |
 Freya Biosciences |
December, 13 ,2023 | Series A | $38,000,000 |
| Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
 DISCO Pharmaceuticals GmbH |
January, 17 ,2024 | Seed | $21,727,000 |
| Gradient Denervation Technologies |
September, 08 ,2023 | Series A | $15,015,000 |
 Bioptimus |
February, 21 ,2024 | Seed | $35,000,000 |
| Mironid® Limited |
September, 14 ,2023 | Series A | |
 Mission Therapeutics |
March, 15 ,2024 | Unknown | $32,101,650 |
| Sitryx |
September, 28 ,2023 | Unknown | $39,500,000 |
 Cure51 |
March, 20 ,2024 | Seed | $16,260,975 |
| Bon Vivant |
October, 13 ,2023 | Seed | $15,800,000 |
 May Health |
May, 14 ,2024 | Series B | $25,000,000 |
| Betteromics |
October, 27 ,2023 | Series A | $20,000,000 |
 Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
| l'école AI |
October, 27 ,2023 | Seed | $3,000,000 |
 Micropep Technologies |
July, 26 ,2024 | Series B | $29,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
 F2G |
September, 13 ,2024 | Unknown | $100,000,000 |
| Freya Biosciences |
December, 13 ,2023 | Series A | $38,000,000 |
| DISCO Pharmaceuticals GmbH |
January, 17 ,2024 | Seed | $21,727,000 |
 Genespire |
September, 26 ,2024 | Series B | $51,969,485 |
| Bioptimus |
February, 21 ,2024 | Seed | $35,000,000 |
| Sofinnova Partners |
November, 15 ,2024 | Series B | Undisclosed Amount |
| Mission Therapeutics |
March, 15 ,2024 | Unknown | $32,101,650 |
| Cure51 |
March, 20 ,2024 | Seed | $16,260,975 |
| May Health |
May, 14 ,2024 | Series B | $25,000,000 |
| Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
| Micropep Technologies |
July, 26 ,2024 | Series B | $29,000,000 |
| F2G |
September, 13 ,2024 | Unknown | $100,000,000 |
| Genespire |
September, 26 ,2024 | Series B | $51,969,485 |
| Sofinnova Partners |
November, 15 ,2024 | Series B | Undisclosed Amount |
 Latent Labs |
February, 14 ,2025 | Unknown | $50,000,000 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
